About Delphi Genetics
Delphi Genetics is a company based in Charleroi (Belgium) founded in 2001 was acquired by Catalent in February 2021.. Delphi Genetics has raised $1.09 million across 2 funding rounds from investors including Catalent, Belfius and BNP Paribas Fortis. Delphi Genetics offers products and services including Plasmid DNA Manufacturing, Cell Therapy Services, and Viral Vector Production. Delphi Genetics operates in a competitive market with competitors including Somalogic, Nautilus Biotechnology, Amunix, Biognosys and Elektrofi, among others.
- Headquarter Charleroi, Belgium
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Delphi Genetics
Delphi Genetics offers a comprehensive portfolio of products and services, including Plasmid DNA Manufacturing, Cell Therapy Services, and Viral Vector Production. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Development and production of plasmid DNA for gene therapy applications.
Process development and CGMP manufacturing for cell therapies.
Manufacturing of viral vectors for therapeutic applications.
Funding Insights of Delphi Genetics
Delphi Genetics has successfully raised a total of $1.09M across 2 strategic funding rounds. The most recent funding activity was a Debt – Conventional round of $3.75 million completed in June 2016. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Debt – Conventional — $3.7M
-
First Round
First Round
(10 Mar 2015)
- Investors Count 5
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun, 2016 | Amount | Debt – Conventional - Delphi Genetics | Valuation |
investors |
|
| Mar, 2015 | Amount | Series A - Delphi Genetics | Valuation | Sambrinvest , Invest4 |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Delphi Genetics
Delphi Genetics has secured backing from 6 investors, including venture fund and institutional investors. Prominent investors backing the company include Catalent, Belfius and BNP Paribas Fortis. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
VC & PE fund
|
Founded Year | Domain | Location | |
|
Theodorus is engaged in managing investment funds for research innovation.
|
Founded Year | Domain | Location | |
|
Retail banking services are offered across multiple sectors.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Delphi Genetics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Delphi Genetics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Delphi Genetics Comparisons
Competitors of Delphi Genetics
Delphi Genetics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Somalogic, Nautilus Biotechnology, Amunix, Biognosys and Elektrofi, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Protein-based assays are developed for life science research.
|
|
| domain | founded_year | HQ Location |
A proteomics platform is developed for analyzing the human proteome.
|
|
| domain | founded_year | HQ Location |
Peptide-based therapeutics are developed for cancers and immune disorders.
|
|
| domain | founded_year | HQ Location |
Proteomics services are delivered via discovery and targeted platforms.
|
|
| domain | founded_year | HQ Location |
Digital platform transforming the delivery of biologic medicines
|
|
| domain | founded_year | HQ Location |
Provider tools to help researchers with protein analysis
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Delphi Genetics
Frequently Asked Questions about Delphi Genetics
When was Delphi Genetics founded?
Delphi Genetics was founded in 2001 and raised its 1st funding round 14 years after it was founded.
Where is Delphi Genetics located?
Delphi Genetics is headquartered in Charleroi, Belgium. It is registered at Charleroi, Walloon Region, Belgium.
Is Delphi Genetics a funded company?
Delphi Genetics is a funded company, having raised a total of $1.09M across 2 funding rounds to date. The company's 1st funding round was a Series A of $1.09M, raised on Mar 10, 2015.
What does Delphi Genetics do?
Founded in 2001 and based in Charleroi, Belgium, Delphi Genetics operates in the biotechnology sector. Services encompass molecular biology research, protein engineering, and antibody development, with core expertise in plasmid DNA applications. Modular offerings span gene synthesis to protein production. A proprietary Staby technology has been developed for plasmid stabilization and expression without antibiotic resistance genes.
Who are the top competitors of Delphi Genetics?
Delphi Genetics's top competitors include Somalogic, Nautilus Biotechnology and Elektrofi.
What products or services does Delphi Genetics offer?
Delphi Genetics offers Plasmid DNA Manufacturing, Cell Therapy Services, and Viral Vector Production.
Who are Delphi Genetics's investors?
Delphi Genetics has 6 investors. Key investors include Catalent, Belfius, BNP Paribas Fortis, Sambrinvest, and Invest4.